Get startedLog in
    Picture of Skye Bioscience logo

    SKYE — Skye Bioscience News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Skye Bioscience Inc expected to post a loss of 29 cents a share - Earnings Preview

    Picture of Skye Bioscience logoSkye Bioscience
    06/05/2025 22:07
    Skye Bioscience Inc SKYE.OQ SKYE.O is expected to show no change in quarterly revenue when it reports  results on May 8 (estimated) for the period ending March 31 2025

‚ÄčLSEG's mean analyst estimate for Skye Bioscience Inc is for a loss of 29 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for Skye Bioscience Inc is $17.50‚Äč, above‚Äč its last closing price of $1.99. ‚Äč‚Äč‚Äč

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč


    QUARTER ENDINGSTARMINESMARTESTIMATE¬ģLSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
    Dec. 31 2024-0.27-0.28-0.24Beat15.5
    Sep. 30 2024-0.25-0.25-0.10Beat60.1
    Jun. 30 2024-0.21-0.19-0.20Missed-2.6‚Äč
    Mar. 31 2024-0.16-0.16-0.18Missed-12.5
    ‚Äč‚ÄčDec. 31 2023-0.38-0.38-0.63Missed-65.8
    ‚Äč
    

This summary was machine generated May 6 at 21:07 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

    Recent news on Skye Bioscience

    See all news